The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Osteosarcoma treatment: state of the art
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cai, J., Jiang, W. G., Grant, M. B., & Boulton, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507401200 · Cited by 235
Retracted(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K., & Tjian, R. (1987) · Science · doi:10.1126/science.2825349 · Cited by 1,321
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Waldmann, T. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1901 · Cited by 1,178
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e · Cited by 1,090
Clinical Orthopaedics and Related Research
TL, &. (1966) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196607000-00044 · Cited by 891
Journal of the National Cancer Institute
(1969) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1387 · Cited by 832
The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*
MANKIN, H. J., MANKIN, C. J., & SIMON, M. A. (1996) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199605000-00004 · Cited by 773
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
Waldmann, T. A., & Tagaya, Y. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.19 · Cited by 721
Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.031 · Cited by 717
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
Khanna, C., Wan, X., Bose, S., Cassaday, R., Olomu, O., Mendoza, A., Yeung, C., Gorlick, R., Hewitt, S. M., & Helman, L. J. (2004) · Nature Medicine · doi:10.1038/nm982 · Cited by 705
Biology and Therapeutic Advances for Pediatric Osteosarcoma
Marina, N., Gebhardt, M., Teot, L., & Gorlick, R. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-422 · Cited by 671
Primary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., De Paolis, M., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 631
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
Eilber, F., Giuliano, A., Eckardt, J., Patterson, K., Moseley, S., & Goodnight, J. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.21 · Cited by 529
Jonasch, E., & Haluska, F. G. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-34 · Cited by 518
Osteosarcoma (Osteogenic sarcoma)
Picci, P. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-6 · Cited by 505
Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M., Horimoto, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13221 · Cited by 492
Provisor, A. J., Ettinger, L. J., Nachman, J. B., Krailo, M. D., Makley, J. T., Yunis, E. J., Huvos, A. G., Betcher, D. L., Baum, E. S., Kisker, C. T., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.76 · Cited by 461
Dahlin's Bone Tumors. General Aspects and Data on 11,087 Cases
Devaney, K. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00019 · Cited by 439
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 435
Volpert, O. V., Zaichuk, T., Zhou, W., Reiher, F., Ferguson, T. A., Stuart, P. M., Amin, M., & Bouck, N. P. (2002) · Nature Medicine · doi:10.1038/nm0402-349 · Cited by 420
Souhami, R. L., Craft, A. W., Van der Eijken, J. W., Nooij, M., Spooner, D., Bramwell, V. H., Wierzbicki, R., Malcolm, A. J., Kirkpatrick, A., Uscinska, B. M., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02307-6 · Cited by 383
Fuchs, N., Bielack, S. S., Epler, D., Bieling, P., Delling, G., Körholz, D., Graf, N., Heise, U., Jürgens, H., Kotz, R., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008391103132 · Cited by 343
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
Ozaki, T., Flege, S., Kevric, M., Lindner, N., Maas, R., Delling, G., Schwarz, R., von Hochstetter, A. R., Salzer-Kuntschik, M., Berdel, W. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.142 · Cited by 342
Wang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338
Endogenous angiogenesis inhibitors
FOLKMAN, J. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0809.x · Cited by 321
MRI and CT evaluation of primary bone and soft-tissue tumors
Aisen, A., Martel, W., Braunstein, E., McMillin, K., Phillips, W., & Kling, T. (1986) · American Journal of Roentgenology · doi:10.2214/ajr.146.4.749 · Cited by 316
Virus Induction of Osteosarcomas in Mice
Finkel, M. P., Biskis, B. O., & Jinkins, P. B. (1966) · Science · doi:10.1126/science.151.3711.698 · Cited by 307
(2000) · PubMed · Cited by 304
Meyers, P. A., & Gorlick, R. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70540-x · Cited by 299
Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.
Wittig, J. C., Bickels, J., Priebat, D. A., Jelinek, J. S., Kellar-Graney, K., Shmookler, B. M., & Malawer, M. M. (2002) · PubMed · Cited by 299
Current Treatment of Osteosarcoma
Ferguson, W. S., & Goorin, A. M. (2001) · Cancer Investigation · doi:10.1081/cnv-100102557 · Cited by 295
Osteosarcoma of the spine: Experience of the Cooperative Osteosarcoma Study Group
Ozaki, T., Flege, S., Liljenqvist, U., Hillmann, A., Delling, G., Salzer‐Kuntschik, M., Jürgens, H., Kotz, R., Winkelmann, W., & Bielack, S. S. (2002) · Cancer · doi:10.1002/cncr.10258 · Cited by 283
Skubitz, K. M., & D'Adamo, D. R. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1409 · Cited by 277
Tumor size and prognosis in aggressively treated osteosarcoma.
Bieling, P., Rehan, N., Winkler, P., Helmke, K., Maas, R., Fuchs, N., Bielack, S., Heise, U., Jurgens, H., Treuner, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.848 · Cited by 275
Picci, P., Bacci, G., Campanacci, M., Gasparini, M., Pilotti, S., Cerasoli, S., Bertoni, F., Guerra, A., Capanna, R., Albisinni, U., et al. (1985) · Cancer · doi:10.1002/1097-0142(19851001)56:7<1515::aid-cncr2820560707>3.0.co;2-6 · Cited by 274
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
Teodoro, J. G., Evans, S. K., & Green, M. R. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0221-2 · Cited by 260
Link, M., Goorin, A. M., Horowitz, M. M., et al. (1991) · PubMed · Cited by 259
A review of clinical and molecular prognostic factors in osteosarcoma
Clark, J. C. M., Dass, C. R., & Choong, P. F. M. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0330-x · Cited by 250
Self-citationFuchs, B., & Pritchard, D. J. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00007 · Cited by 248
Comparative Aspects of Osteosarcoma: Dog Versus Man
WITHROW, S. J., POWERS, B. E., STRAW, R. C., & WILKINS, R. M. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00023 · Cited by 235
Ezrin, a key component in tumor metastasis
Hunter, K. W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.03.001 · Cited by 229
Hereditary chronic pancreatitis
Rosendahl, J., Bödeker, H., Mössner, J., & Teich, N. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-1 · Cited by 225
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
Ferrari, S., & Palmerini, E. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328122d73f · Cited by 219
Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma
Wan, X., Mendoza, A., Khanna, C., & Helman, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3135 · Cited by 216
National Cancer Institute Monograph
(1967) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/38.6.998 · Cited by 211
Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis
Choong, P., & Nadesapillai, A. P. W. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo0000093845.72468.bd · Cited by 208
Self-citationErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma
Onda, M., Matsuda, S., Higaki, S., Iijima, T., Fukushima, J.-I., Yokokura, A., Kojima, T., Horiuchi, H., Kurokawa, T., & Yamamoto, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960101)77:1<71::aid-cncr13>3.0.co;2-5 · Cited by 201
Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
McIntyre, J. F., Smith-Sorensen, B., Friend, S. H., Kassell, J., Borresen, A. L., Yan, Y. X., Russo, C., Sato, J., Barbier, N., & Miser, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.925 · Cited by 200
Alterations of thep53, Rb andMDM2 genes in osteosarcoms
Miller, C. W., Aslo, A., Won, A., Tan, M., Lampkin, B., & Koefflar, H. P. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213553 · Cited by 190
Hudson, M., Jaffe, M. R., Jaffe, N., Ayala, A., Raymond, A. K., Carrasco, H., Wallace, S., Murray, J., & Robertson, R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.12.1988 · Cited by 189
Petrilli, A. S., de Camargo, B., Filho, V. O., Bruniera, P., Brunetto, A. L., Jesus-Garcia, R., Camargo, O. P., Pena, W., Péricles, P., Davi, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.5352 · Cited by 188
LINK, M. P., GOORIN, A. M., HOROWITZ, M., MEYER, W. H., BELASCO, J., BAKER, A., AYALA, A., & SHUSTER, J. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00003 · Cited by 171
Laverdière, C., Hoang, B. H., Yang, R. R., Sowers, R. S., Qin, J., Meyers, P. A., Huvos, A. G., Healey, J. H., & Gorlick, R. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1089 · Cited by 168
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
Choong, P., & Nadesapillai, A. P. W. (2003) · PubMed · doi:10.1097/01.blo.0000093845.72468.bd · Cited by 167
Self-citationStature and malignant tumors of bone in childhood and adolescence
Fraumeni, J. F. (1967) · Cancer · Cited by 150
Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the Extremities
Machak, G. N., Si, T., Solovyev, Y. N., Sinyukov, P. A., Ivanov, S. M., Кочергина, Н. В., Ryjkov, A. D., Тепляков, В. В., Bokhyan, B. Y., & Glebovskaya, V. V. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.2.147 · Cited by 149
Bacci, G., Longhi, A., Fagioli, F., Briccoli, A., Versari, M., & Picci, P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.026 · Cited by 149
Expression Profiles of Osteosarcoma That Can Predict Response to Chemotherapy
Man, T., Chintagumpala, M., Visvanathan, J., Shen, J., Perlaky, L., Hicks, J. M., Johnson, M., Davino, N. A., Murray, J. C., Helman, L. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0985 · Cited by 146
Nardin, A., Lefebvre, M., Labroquère, K., Faure, O., & Abastado, J. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056473 · Cited by 145
Canine Bone Sarcoma: Estimation of Relative Risk as a Function of Body Size
Ra, T. (1966) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/36.6.1137 · Cited by 139
Skip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
Kager, L., Zoubek, A., Kastner, U., Kempf‐Bielack, B., Potratz, J. C., Kotz, R. I., Exner, G. U., Franzius, C., Lang, S., Maas, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2978 · Cited by 139
Perissinotto, E., Cavalloni, G., Leone, F., Fonsato, V., Mitola, S. M. F., Grignani, G., Surrenti, N., Sangiolo, D., Bussolino, F., Piacibello, W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.490.11.2 · Cited by 135
P-glycoprotein Expression: Critical Determinant in the Response to Osteosarcoma Chemotherapy
Chan, H. S. L., Haddad, G., DeBoer, G., Ling, V. W. T., & Grogan, T. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.22.1706 · Cited by 132
Stature of young people with malignant bone tumors
Cotterill, S. J., Wright, C. M., Pearce, M. S., & Craft, A. W. (2003) · Pediatric Blood & Cancer · doi:10.1002/pbc.10437 · Cited by 129
Abe, R., Shimizu, T., Yamagishi, S., Shibaki, A., Amano, S., Inagaki, Y., Watanabe, H., Sugawara, H., Nakamura, H., Takeuchi, M., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63210-5 · Cited by 126
The Staging and Surgery of Musculoskeletal Neoplasms
Wolf, R. E., & Enneking, W. F. (1996) · Orthopedic Clinics of North America · doi:10.1016/s0030-5898(20)32093-9 · Cited by 125
Zhou, H., Randall, R. L., Brothman, A. R., Maxwell, T. M., Coffin, C. M., & Goldsby, R. E. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200301000-00007 · Cited by 125
IGF‐1 receptor contributes to the malignant phenotype in human and canine osteosarcoma
MacEwen, E. G., Pastor, J., Kutzke, J., Tsan, R. Z., Kurzman, I. D., Thamm, D. H., Wilson, M., & Radinsky, R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20046 · Cited by 118
Jaffe, N., Carrasco, H., Raymond, K. A., Ayala, A. G., & Eftekhari, F. (2002) · Cancer · doi:10.1002/cncr.10944 · Cited by 117
Daw, N. C., Billups, C. A., Galindo, C. R., McCarville, M. B., Rao, B. N., Cain, A. M., Jenkins, J. J., Neel, M. D., & Meyer, W. H. (2005) · Cancer · doi:10.1002/cncr.21626 · Cited by 112
Franchi, A., Arganini, L., Baroni, G., Calzolari, A., Capanna, R., Campanacci, D. A., Caldora, P., Masi, L., Brandi, M. L., & Zampi, G. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<284::aid-path94>3.0.co;2-z · Cited by 112
Dass, C. R., Ek, E. T., Contreras, K. G., & Choong, P. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9046-6 · Cited by 106
Self-citationHeight as a Risk Factor for Osteosarcoma
Longhi, A., Pasini, A., Cicognani, A., Baronio, F., Pellacani, A. U. E., Baldini, N., & Bacci, G. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000169251.57611.8e · Cited by 92
Growth and development and other risk factors for osteosarcoma in children and young adults
Gelberg, K. H., Fitzgerald, E., Hwang, S. E., & Dubrow, R. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.2.272 · Cited by 89
Ek, E. T., Dass, C. R., Contreras, K. G., & Choong, P. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701044 · Cited by 87
Self-citationAnticancer effects of zoledronic acid against human osteosarcoma cells
Kubista, B., Trieb, K., Sevelda, F., Toma, C. D., Arrich, F., Heffeter, P., Elbling, L., Sutterlüty, H., Scotlandi, K., Kotz, R. I., et al. (2006) · Journal of Orthopaedic Research® · doi:10.1002/jor.20129 · Cited by 86
Müller, C. R., Smeland, S., Bauer, H. C. F., Sæter, G., & Strander, H. A. (2005) · Acta Oncologica · doi:10.1080/02841860510029978 · Cited by 84
Inhibition of Metastatic Behavior of Murine Osteosarcoma by Hypophysectomy
Pollak, M., Sem, A., Richard, M., Tetenes, E., & Bell, R. S. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.12.966 · Cited by 81
p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome
Nakase, M., Inui, M., Okumura, K., Kamei, T., Nakamura, S., & Tagawa, T. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0196 · Cited by 81
Eselgrim, M., Grunert, H., Kühne, T., Zoubek, A., Kevric, M., Buerger, H., Jürgens, H., Mayer‐Steinacker, R., Gosheger, G., & Bielack, S. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20608 · Cited by 79
Prognostic Relevance of Increased Angiogenesis in Osteosarcoma
Kreuter, M., Bieker, R., Bielack, S., Auras, T., Buerger, H., Gosheger, G., Jürgens, H., Berdel, W. E., & Mesters, R. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0969 · Cited by 78
Received Dose and Dose-Intensity of Chemotherapy and Outcome in Nonmetastatic Extremity Osteosarcoma
Lewis, I. J., Weeden, S., Machin, D., Stark, D., Craft, A. W., & Intergroup, F. T. E. O. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4028 · Cited by 78
Osteosarcoma in Preadolescent Patients
Rytting, M., Pearson, P., Raymond, A. K., Ayala, A. G., Murray, J. A., Yasko, A. W., Johnson, M., & Jaffe, N. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200004000-00007 · Cited by 75
Surgical management of adrenal metastases from lung cancer
Beitler, A. L., Urschel, J. D., Velagapudi, S., & Takita, H. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199809)69:1<21::aid-jso5>3.0.co;2-m · Cited by 75
Chawla, S. P., Tolcher, A. W., Staddon, A. P., Schuetze, S. M., D’Amato, G. Z., Blay, J., Sankhala, K. K., Daly, S. T., Rivera, V. M., & Demetri, G. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.9505 · Cited by 74
Bacci, G., Longhi, A., Ferrari, S., Briccoli, A., Donati, D. M., PAOLIS, M. D., & Versari, M. (2004) · Tumori Journal · doi:10.1177/030089160409000507 · Cited by 73
Densmore, C. L., Kleinerman, E. S., Gautam, A. K., Jia, S.-F., Xu, B., Worth, L. L., Waldrep, J. C., Fung, Y. K., Tang, A., & Knight, V. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700343 · Cited by 70
P‐glycoprotein expression in osteosarcoma: A basis for risk‐adapted adjuvant chemotherapy
Baldini, N., Scotlandi, K., Serra, M., Picci, P., Bacci, G., Sottili, S., & Campanacci, M. (1999) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100170502 · Cited by 65
Endostatin therapy reveals a U-shaped curve for antitumor activity
Sjin, R. M. T. T., Naspinski, J., Birsner, A. E., Li, C., Chan, R., Lo, K.-M., Gillies, S. D., Zurakowski, D., Folkman, J., Samulski, J. R., et al. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700938 · Cited by 61
Sekyi-Otu, A., Bell, R. S., Ohashi, C., Pollak, M., & Andrulis, I. L. (1995) · PubMed · Cited by 60
Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas
Choong, P., Fernö, M., Åkerman, M., Willén, H., Långström, E., Gustaeson, P., Alvegård, T. A., & Rydholm, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960822)69:4<268::aid-ijc5>3.0.co;2-v · Cited by 60
Self-citationAnti-angiogenic therapy for osteosarcoma
Quan, G. M. Y., & Choong, P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9031-1 · Cited by 59
Self-citationExtracorporeal irradiation for malignant bone tumors
Hong, A., Stevens, G. N., Stalley, P., Pendlebury, S. C., Ahern, V., Ralston, A., Estoesta, E., & Barrett, I. R. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01460-2 · Cited by 58
Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs
Tomlin, J. L., Sturgeon, C., Pead, M. J., & Muir, P. (2000) · Veterinary Record · doi:10.1136/vr.147.5.129 · Cited by 58
Horie, N., Murata, H., Kimura, S. H., Takeshita, H., Sakabe, T., Matsui, T., Maekawa, T., Kubo, T., & Fushiki, S. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603548 · Cited by 57
Yang, R., Hoang, B. H., Kubo, T., Kawano, H., Chou, A. J., Sowers, R. S., Huvos, A. G., Meyers, P. A., Healey, J. H., & Gorlick, R. G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22749 · Cited by 56
Kang, H.-G., Kim, H., Kim, K., Oh, J. H., Lee, M., Seol, S. M., & Han, I. (2007) · Journal of Orthopaedic Research® · doi:10.1002/jor.20323 · Cited by 56
Mansky, P. J., Liewehr, D. J., Steinberg, S. M., Chrousos, G. P., Avila, N. A., Long, L., Bernstein, D. B., Mackall, C. L., Hawkins, D. S., & Helman, L. J. (2002) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200208000-00007 · Cited by 56
Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma
Dass, C. R., Nadesapillai, A. P. W., Robin, D., Howard, M. L., Fisher, J., Zhou, H., & Choong, P. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9004-3 · Cited by 55
Self-citationAdjuvant Interferon Treatment of Human Osteosarcoma
Strander, H. A., Adamson, U. K. C., Aparisi, T., Broström, L., Cantell, K., Einhorn, S., Hall, K. E., Ingimarsson, S., Nilsonne, U., & Söderberg, G. (1979) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-81332-0_7 · Cited by 52
Ciccone, W. J., Bratton, D. R., Weinstein, D. M., & Elias, J. J. (2006) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.e.00576 · Cited by 51
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients
Bacci, G., Fabbri, N., Balladelli, A., Forni, C., Palmerini, E., & Picci, P. (2006) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.88b8.17809 · Cited by 50
Kubo, T., Shimose, S., Matsuo, T., Tanaka, K., Yasunaga, Y., Sakai, A., & Ochi, M. (2006) · Journal of Orthopaedic Research® · doi:10.1002/jor.20177 · Cited by 46
Putative role for EPC‐1/PEDF in the G0 growth arrest of human diploid fibroblasts
Pignolo, R. J., Francis, M. K., Rotenberg, M. O., & Cristofalo, V. J. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10212 · Cited by 44
Winkler, K., Beron, G., Kotz, R. I., Salzer-Kuntschik, M., Beck, J. D., Beck, W., Brandeis, W. E., Ebell, W., Erttmann, R., G�bel, U., et al. (1983) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00625042 · Cited by 44
Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells
Benassi, M. S., Chiechi, A., Ponticelli, F., Pazzaglia, L., Gamberi, G., Zanella, L., Manara, M. C., Perego, P., Ferrari, S. M., & Picci, P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.10.004 · Cited by 43
Selby, P., & Bailey, C. (1996) · BMJ Publishing Group eBooks · Cited by 38
Ek, E. T., Ojaimi, J., Kitagawa, Y., & Choong, P. (2006) · Oncology Reports · doi:10.3892/or.16.1.17 · Cited by 38
Self-citationLuksch, R., Perotti, D., Cefalo, G., Gambacorti-Passerini, C. B., Massimino, M., Spreafico, F., Casanova, M., Ferrari, A., Terenziani, M., Polastri, D., et al. (2003) · Tumori Journal · doi:10.1177/030089160308900306 · Cited by 37
Vinodhkumar, R., Song, Y., Ravikumar, V., Ramakrishnan, G., & Devaki, T. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.012 · Cited by 36
c-Jun knockdown sensitizes osteosarcoma to doxorubicin
Dass, C. R., Khachigian, L. M., & Choong, P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0086 · Cited by 34
Self-citationMammalian target of rapamycin inhibitors in sarcomas
Okuno, S. H. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000228742.72165.cf · Cited by 33
European Osteosarcoma Intergroup
van der Eijken, J. W. (1989) · Springer eBooks · doi:10.1007/978-4-431-68072-7_18 · Cited by 32
Shin, C. Y., Lee, W. J., Choi, J. W., Choi, M. S., Ryu, J. R., Oh, S. J., Cheong, J. H., Choi, E. Y., & Ko, K. H. (2007) · Nitric Oxide · doi:10.1016/j.niox.2007.03.004 · Cited by 31
Inaba, H., Glibetić, M., Buck, S. A., Ravindranath, Y., & Kaplan, J. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20151 · Cited by 30
Dass, C. R., Khachigian, L. M., & Choong, P. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0036 · Cited by 30
Self-citationClinical importance of late recurrence in soft-tissue sarcomas
Gibbs, J. F., Lee, R. J., Driscoll, D. L., McGrath, B. E., Mindell, E. R., & Kraybill, W. G. (2000) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(200002)73:2<125::aid-jso14>3.0.co;2-5 · Cited by 27
Yuan, X.-W., Zhu, X., Huang, X.-F., Sheng, P.-Y., He, A.-S., Yang, Z.-B., Deng, R., Feng, G., & Liao, W.-M. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00662.x · Cited by 26
Engels, E. A. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.197 · Cited by 25
Katsoulas, A., Rachid, Z., McNamee, J. P., Williams, C., & Jean‐Claude, B. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0179 · Cited by 24
Schwartz, Y., Avraham, R., Benish, M., Rosenne, E., & Ben‐Eliyahu, S. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9540-9 · Cited by 24
Radiation-Induced Osteosarcoma Arising 20 years after the Treatment of Ewing's Sarcoma
Longhi, A., Barbieri, E., Fabbri, N., Macchiagodena, M., Favale, L., Lippo, C., Salducca, N., & Bacci, G. (2003) · Tumori Journal · doi:10.1177/030089160308900526 · Cited by 21
Xiang-wei, Yuan, Xiaofeng, et al. (2007) · 中国药理学报:英文版 · Cited by 17
Interferon-alpha Enhances the Sensitivity of Human Osteosarcoma Cells to Etoposide
Jia, S.-F., An, T., Worth, L. L., & Kleinerman, E. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313758 · Cited by 14
Adjuvant interferon treatment in human osteosarcoma
Strander, H. A., Bauer, H. C. F., Brosjö, O., Andris Kreicbergs, A., Lindholm, J., Nilsonne, U., Silfverswärd, C., & Szamosi, A. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3518-8_5 · Cited by 13
Cited by
Osteosarcoma treatment – Where do we stand? A state of the art review
Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,234
The Molecular Pathogenesis of Osteosarcoma: A Review
Broadhead, M. L., Clark, J. C. M., Myers, D. E., Dass, C. R., & Choong, P. F. M. (2011) · Sarcoma · doi:10.1155/2011/959248 · Cited by 346
Self-citationMetastatic osteosarcoma: a challenging multidisciplinary treatment
Meazza, C., & Scanagatta, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1168697 · Cited by 298
Simpson, S., Dunning, M. D., de Brot, S., Grau-Roma, L., Mongan, N. P., & Rutland, C. S. (2017) · Acta Veterinaria Scandinavica · doi:10.1186/s13028-017-0341-9 · Cited by 284
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y., Yock, T. I., Ebb, D. H., Choy, E., Raskin, K. A., Liebsch, N., et al. (2011) · Cancer · doi:10.1002/cncr.26037 · Cited by 191
“Anthracyclines and cisplatin, as well as methotrexate or ifosfamide, form the backbone of systemic treatments.(1) After chemotherapy induction, complete surgical resection generally yields high rates of local control in patients with extremity lesions.”
Background
Metadata
- Authors
- Ta, H. T., Dass, C. R., Choong, P. F. M., & Dunstan, D. E.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2009-02-12
- Volume
- 28
- Issue
- 1-2
- Pages
- 247-263
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2083239828
- Cited by
- 314
- References
- 132
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.